CTLA4 +49AG (rs231775) and CT60 (rs3087243) gene variants are not associated with alopecia areata in a Mexican population from Monterrey Mexico☆☆☆

[1]  F. Henriquez,et al.  Alopecia areata: A multifactorial autoimmune condition. , 2019, Journal of autoimmunity.

[2]  M. Senna,et al.  Alopecia areata: a review of disease pathogenesis , 2018, The British journal of dermatology.

[3]  S. Ghaderian,et al.  Genetic variant association of PTPN22, CTLA4, IL2RA, as well as HLA frequencies in susceptibility to alopecia areata , 2018, Immunological investigations.

[4]  A. Gawad,et al.  Polymorphism of FAS and FAS Ligand Genes in Alopecia Areata: A Case–control Study in Egyptian Population , 2018, Indian journal of dermatology.

[5]  R. Dursun,et al.  Association of Cytotoxic T Lymphocyte Antigen-4 Gene Polymorphisms with Psoriasis Vulgaris: A Case-Control Study in Turkish Population , 2018, Journal of immunology research.

[6]  R. Trüeb,et al.  Alopecia Areata: a Comprehensive Review of Pathogenesis and Management , 2018, Clinical Reviews in Allergy & Immunology.

[7]  D. Sansom,et al.  CTLA-4: a moving target in immunotherapy. , 2018, Blood.

[8]  Xuehao Wang,et al.  CTLA-4 +49 G/A Polymorphism Confers Autoimmune Disease Risk: An Updated Meta-Analysis. , 2017, Genetic testing and molecular biomarkers.

[9]  F. Lo,et al.  Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study , 2016, PLoS ONE.

[10]  J. Ocampo-Candiani,et al.  Association between PTPN22 C1858T polymorphism and alopecia areata risk. , 2015, Experimental and therapeutic medicine.

[11]  A. Rudensky,et al.  Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity , 2015, The Journal of experimental medicine.

[12]  Sanquan Zhang,et al.  Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies. , 2015, Gene.

[13]  M. Miteva,et al.  Epidemiology and burden of alopecia areata: a systematic review , 2015, Clinical, cosmetic and investigational dermatology.

[14]  M. Daly,et al.  Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci , 2015, Nature Communications.

[15]  Liang Sun,et al.  CTLA4 Variants and Haplotype Contribute Genetic Susceptibility to Myasthenia Gravis in Northern Chinese Population , 2014, PloS one.

[16]  H. Rangel-Villalobos,et al.  The −319C/+49G/CT60G Haplotype of CTLA-4 Gene Confers Susceptibility to Rheumatoid Arthritis in Mexican Population , 2013, Cell Biochemistry and Biophysics.

[17]  B. Mora,et al.  Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case–control association study in the Italian population , 2013, Archives of Dermatological Research.

[18]  M. Nöthen,et al.  Genetic variants in CTLA4 are strongly associated with alopecia areata. , 2011, The Journal of investigative dermatology.

[19]  Rongqiang Zhang,et al.  Pathogenesis of Alopecia Areata Based on Bioinformatics Analysis , 2019, Indian journal of dermatology.

[20]  K. Jamil,et al.  CTLA-4 A49G GENE POLYMORPHISM IS NOT ASSOCIATED WITH VITILIGO IN SOUTH INDIAN POPULATION , 2010, Indian journal of dermatology.